文献速递甲状腺与浅表头颈US

探索良性甲状腺结节射频消融后优化的随访时机:系统综述与Meta分析

Searching for optimized follow-up timing after radiofrequency ablation of benign thyroid nodules: Systematic review and Meta-analysis.
PubMed 文献 · Eur J Radiol · 2025-11-17

该系统综述与Meta分析纳入29项研究共3033个良性甲状腺结节,评估射频消融后不同随访间隔的体积缩小率(VRR)。汇总VRR在1、3、6、12个月分别为42.96%、61.80%、69.89%、77.86%。作者认为1-3个月早期评估加12个月最终评估的简化随访方案对多数患者可能足够。

要点

  • 射频消融后1、3、6、12个月汇总VRR分别为42.96%、61.80%、69.89%、77.86%。
  • 小体积组(<15 mL)各随访点VRR均显著变化,大体积组(≥30 mL)仅6-12个月间显著变化。
  • 作者认为1-3个月早期评估加12个月最终评估的简化随访方案对多数患者可能足够。

核心结论

  • 作者认为由1-3个月早期评估和12个月最终评估两次超声组成的简化随访方案对多数患者可能足够,可指导临床决策并提供RFA疗效基准。

研究设计与样本

  • 系统综述与Meta分析,检索截至2025年1月17日发表的文献,纳入29项研究报告RFA治疗良性甲状腺结节,共3033个结节,提取1、3、6、12个月随访的VRR。

诊断标准与关键数值

  • 汇总VRR在1个月为42.96%(95%CI:35.06-50.87)、3个月为61.80%(95%CI:57.66-65.95)、6个月为69.89%(95%CI:67.08-72.69)、12个月为77.86%(95%CI:75.89-79.67)。

临床应用与阅片要点

  • 作者认为1-3个月早期评估和12个月最终评估两次超声的简化随访方案对多数患者可能足够,可指导临床决策并提供RFA疗效基准。

局限性

  • Meta回归分析显示基线平均结节体积与6个月和12个月VRR呈负相关(p<0.01)。
  • 原文结论称这些强烈发现可指导临床决策,但未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The primary objective of this study was to determine the optimal ultrasound(US) follow-up timing after radiofrequency ablation(RFA) for benign thyroid nodules(BTNs),conducting a systematic review and meta-analysis of published data on volume reduction rate(VRR) outcomes across different follow-up intervals.

DESIGN AND METHODS: A systematic search of articles published up to January 17, 2025 identified studies reporting RFA treatment for BTNs. Characteristics of the study design, BTNs cohorts, and outcomes of interest(VRR at 1,3,6 and 12 months of follow up) were extracted. Statistical analysis included a random-effects meta-analysis, assessment of heterogeneity with use of the I2 statistic, and meta-regression and subgroup analyses to explore potential sources of heterogeneity.

RESULTS: Twenty-nine studies comprising 3033 BTNs were included.The pooled VRRs at 1,3,6, and 12 months post-RFA were 42.96 %(95 %CI:35.06-50.87),61.80 %(95 %CI:57.66-65.95),69.89 %(95 %CI:67.08-72.69), and 77.86 %(95 %CI:75.89-79.67),respectively. Meta-regression analysis using baseline mean BTN volume revealed an inverse correlation with VRR at both 6 and 12 months(p < 0.01).Small-volume group(<15 mL):Significant changes in VRR were observed between 1-[45.76 %(95 %CI:38.22-53.29)],3-[63.91 %(95 %CI:58.84-68.99)], 6-[74.59 %(95 %CI:71.08-78.11)], and 12-month[81.42 %(95 %CI:78.56-84.29)] follow-ups.Medium-volume group(15-30 mL):Significant changes were noted between 1[47.09 %(95 %CI:40.84-53.34)] and 3 months[63.05 %(95 %CI:60.14-65.96)],and between 6[67.91 %(95 %CI:65.13-70.70)] and 12 months[75.61 %(95 %CI:71.79-79.45)].Large-volume group(≥30 mL):A significant change in VRR was observed only between the 6-[59 %(95 %CI:54.20-63.81)] and 12-month[69.32 %(95 %CI:64.97-73.68)]follow-ups.

CONCLUSION: A streamlined follow-up schedule consisting of two US assessments-an early evaluation at 1-3 months and a final evaluation at 12 months-can be sufficient for most patients. These strong findings can guide clinical decision-making, provide a benchmark for RFA efficacy, and support the optimization of healthcare resources.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wolde Sellasie S, Deandrea M, Amendola S, et al. Searching for optimized follow-up timing after radiofrequency ablation of benign thyroid nodules: Systematic review and Meta-analysis. Eur J Radiol. 2025. PMID: 41289722. doi:10.1016/j.ejrad.2025.112529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。